Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
University of California, San Diego
University of Pittsburgh
Tempus AI
Sanofi
Incyte Corporation
Incyte Corporation
University of California, San Diego
Hutchmed
Elevation Oncology
NantCell, Inc.
Pfizer
Turning Point Therapeutics, Inc.
NextCure, Inc.
Ipsen
Rutgers, The State University of New Jersey
Columbia University
M.D. Anderson Cancer Center
Nektar Therapeutics
Herlev Hospital
Amgen
Pfizer
Incyte Corporation
Bayer
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
UNC Lineberger Comprehensive Cancer Center
Celgene
Amgen
Novartis
University of California, San Diego
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
Groupe Oncologie Radiotherapie Tete et Cou
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
AbbVie
Altor BioScience
SWOG Cancer Research Network